GLP-1 Prior Authorization: How to Get Insurance Approval (Template Included)
Everything you need to build a bulletproof prior authorization request and maximize your chances of approval.
Getting insurance to cover GLP-1 medications like Wegovy or Zepbound requires navigating the prior authorization process. While the process can feel intimidating, a well-prepared submission significantly increases your chances of approval. This guide walks you through every step and provides templates you can share with your healthcare provider.
Understanding Prior Authorization
Prior authorization is your insurance company's way of verifying that a prescribed medication is medically necessary before agreeing to pay for it. For GLP-1 medications, insurers want to see that:
- You have a qualifying diagnosis (obesity with BMI criteria)
- You have tried other weight loss approaches first (diet, exercise, behavioral counseling)
- The specific medication is appropriate for your situation
- There are no contraindications
- The prescriber is qualified to manage the treatment
Timeline and Process
Prior Authorization Timeline
- Day 1: Provider submits PA request with supporting documentation
- Days 2-5: Insurance reviews the request (standard timeline)
- Day 5-7: Decision rendered -- approved, denied, or more information requested
- If more info requested: Provider submits additional documentation (adds 5-7 days)
- If denied: Appeal must be filed within 30-60 days (varies by insurer)
- Appeal review: 30-60 days for standard appeal; 72 hours for expedited
- External review: If internal appeal fails, external review available in most states
Required Documentation Checklist
Complete PA Submission Package
- Insurance PA form (completed, specific to your insurer)
- Letter of Medical Necessity from prescribing provider
- Recent office visit notes documenting weight, BMI, and obesity discussion
- Weight history (6-12 months of documented weights)
- Documentation of previous weight loss attempts (diet programs, exercise, counseling)
- Comorbidity documentation (lab results, diagnoses, specialist notes)
- Current medication list
- BMI calculation with height and weight clearly documented
Letter of Medical Necessity Template
Template: Share This with Your Provider
[Provider Letterhead]
[Date]
To: [Insurance Company] Medical Review Department
Re: Prior Authorization for [Medication Name] for [Patient Name]
Member ID: [Number] | Group: [Number] | DOB: [Date]
Dear Medical Director,
I am writing to request prior authorization for [Wegovy/Zepbound] for my patient [Name], who has a diagnosis of [obesity/morbid obesity] (ICD-10: [E66.01/E66.09/E66.9]).
Clinical Summary:
- Current weight: [X] lbs | Height: [X] | BMI: [X] kg/m2
- Duration of obesity: [X] years
- Peak weight: [X] lbs
Comorbidities:
- [List each with ICD-10 code and supporting lab values]
- Type 2 diabetes/prediabetes: A1C [X]%
- Hypertension: BP [X/X] mmHg
- Dyslipidemia: LDL [X], HDL [X], TG [X]
- Sleep apnea: AHI [X] events/hour
- [Other relevant conditions]
Previous Weight Loss Attempts:
- [Program/approach], [dates], [results]
- [Program/approach], [dates], [results]
- [Program/approach], [dates], [results]
Rationale for This Medication:
[Specific reasons why this medication is appropriate for this patient, clinical trial data supporting its use, and expected benefits including weight loss and comorbidity improvement]
Contraindications Reviewed:
- No personal/family history of medullary thyroid carcinoma
- No history of MEN2 syndrome
- No history of pancreatitis
- Not currently pregnant or planning pregnancy
This medication is medically necessary to treat [Patient]'s obesity and reduce the risk of [specific complications]. I am available to discuss this request further.
Sincerely,
[Provider Name, Credentials]
[NPI Number] | [Phone] | [Fax]
Strategies to Maximize Approval Chances
- Document everything in advance. Start documenting weight history, diet attempts, and exercise programs months before requesting PA. Insurers want to see a sustained pattern, not a rush to meet criteria.
- Get comorbidity documentation. Lab results showing prediabetes, elevated cholesterol, or other weight-related conditions strengthen the medical necessity argument significantly.
- Use exact criteria language. Find your insurer's specific PA criteria (usually available online or by calling the pharmacy benefits line) and ensure your documentation addresses every criterion explicitly.
- Include clinical trial data. Reference the STEP trials (semaglutide) or SURMOUNT trials (tirzepatide) to support the medication's efficacy for your patient's specific profile.
- Follow up proactively. Call the insurer 3 days after submission to confirm receipt and ask about timeline. Delays often occur because submissions sit in a queue.
If Your PA Is Denied
Do Not Give Up -- Appeal
- Read the denial letter carefully. It must state the specific reason for denial. Address that exact reason in your appeal.
- Request a peer-to-peer review. Your doctor can speak directly with the insurer's medical director to advocate for approval.
- Submit additional documentation. Often, denials result from incomplete submissions. Add any missing documentation.
- File a formal appeal. Use the insurer's appeal process. Include new supporting evidence if available.
- Request external review. If the internal appeal fails, most states allow an independent external review.
- Contact your state insurance commissioner. If you believe the denial is unjustified, your state's insurance department can intervene.
While Waiting for PA Approval
The PA process can take weeks, and you should not wait to start your weight loss journey. Consider these options while waiting:
- Start with compounded medication. Compounded semaglutide at $200-400/month does not require prior authorization and can be started immediately.
- Begin lifestyle changes. Start dietary improvements, exercise, and behavioral strategies. These support both your PA application and your eventual treatment.
- Use manufacturer coupons. Some patients use savings cards or bridge programs while waiting for PA approval.
- Transition if approved. If PA is approved, you can transition from compounded to brand-name medication seamlessly.
Key Takeaways
- Prior authorization approval rates range from 40-80% depending on documentation quality
- A strong letter of medical necessity is the most important component
- Document weight history, comorbidities, and previous weight loss attempts thoroughly
- Address your insurer's specific criteria explicitly in the submission
- If denied, always appeal -- success rates on appeal are approximately 50-60%
- Consider starting compounded GLP-1 treatment while waiting for PA approval
- Share the LMN template with your healthcare provider to streamline the process
Medical Disclaimer: This article is for educational purposes only and does not constitute medical or legal advice. Prior authorization requirements vary by insurance plan. Work with your healthcare provider and insurance company for guidance specific to your plan and situation.
No Prior Authorization Needed
Trimi Health provides GLP-1 access without insurance prior authorization hassles. Start treatment immediately with our affordable programs.
Get Started TodayMore on cost & affordability
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).